StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson IMBRUVICA (ibrutinib) by Year

IMBRUVICA (ibrutinib) — Worldwide currency (FX) impact YoY (%) (%)

QuarterlyAnnual

Johnson & Johnson IMBRUVICA (ibrutinib): 1.5% in FY2025, up 3.2 pts from a year earlier.

Latest, FY2025
1.5%
Period ended Dec 28, 2025
Change on a year earlier
+3.2 pts
-1.7% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| WW | 2,823 | 3,038 | (7.1) | (8.6) | 1.5”

Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIMBRUVICA (ibrutinib) — Worldwide currency (FX) impact YoY (%) (%)Year on yearSource
FY2025Dec 28, 20251.5%+3.2 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
FY2024Dec 29, 2024-1.7%-1.2 ptsForm 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
FY2023Dec 31, 2023-0.5%+5.3 ptsForm 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
FY2022Jan 1, 2023-5.8%-7.5 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20221.7%+2.2 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 2021-0.5%+3.6 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 2019-4.1%-4.9 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20180.8%-0.1 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 20170.9%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson IMBRUVICA (ibrutinib) (%), annual FY2017–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-imbruvica-fx-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.